Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
Sofia Koustoulidou, Mark W. H. Hoorens, Simone U. Dalm, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1100-1100
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance
Pradip De, Jennifer C. Aske, Raed Sulaiman, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1519-1519
Open Access | Times Cited: 16
Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies
A. S. Prashanth, Senthil Kumar Ravichander, Prasad Eswaran, et al.
Nuclear Medicine Communications (2023) Vol. 44, Iss. 4, pp. 276-283
Closed Access | Times Cited: 9
Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT
Meaghan Polack, Sophie C. Hagenaars, Alice M. Couwenberg, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 9, pp. 1776-1784
Open Access | Times Cited: 14
Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment
Qing Zhang, Yang Wang, Fusheng Liu
Cellular Signalling (2022) Vol. 103, pp. 110567-110567
Closed Access | Times Cited: 14
Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors
Sikun Meng, Tomoaki Hara, Yutaka Miura, et al.
Cancer Science (2024) Vol. 115, Iss. 11, pp. 3532-3542
Open Access | Times Cited: 2
First-In-Human Results On The Biodistribution, Pharmacokinetics, And Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2 in Patients with Various End-stage Cancers
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 17
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2
Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3093-3093
Open Access | Times Cited: 2
Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
Christopher Montemagno, Shamir Cassim, Nicolas De Leiris, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6413-6413
Open Access | Times Cited: 15
Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature
Alondra Escudero-Castellanos, Jens Kurth, Surachet Imlimthan, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3202-3213
Open Access | Times Cited: 4
Fibroblast Activation Protein–Targeted PET/CT With Al18F-NODA-FAPI-04 for In Vivo Imaging of Tendon Healing in Rat Achilles Tendon Injury Models
Zhongfan Liu, Haiying Zhou, Pengfei Li, et al.
The American Journal of Sports Medicine (2023) Vol. 51, Iss. 14, pp. 3790-3801
Closed Access | Times Cited: 4
Beyond Small Molecules: Antibodies and peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
(2024)
Open Access | Times Cited: 1
Dimeric FAPI with potential for tumor theranostics.
Chunxia Qin, Yangmeihui Song, Weibo Cai, et al.
PubMed (2021) Vol. 11, Iss. 6, pp. 537-541
Closed Access | Times Cited: 10
Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development
Vladimir Tolmachev, Anzhelika Vorobyeva
Cancers (2022) Vol. 14, Iss. 2, pp. 297-297
Open Access | Times Cited: 7
FAP-Liganden – Potenziale in der nuklearmedizinischen Bildgebung und Theranostik
Yuriko Mori, Katharina Dendl, Emil Novruzov, et al.
Springer eBooks (2024), pp. 725-739
Closed Access
Unveiling immune cell response disparities in human primary cancer-associated fibroblasts between two- and three-dimensional cultures
Jianping Yang, Nikhil N Kulkarni, Masashi Yamaji, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0314227-e0314227
Open Access
The Role of Inflammatory Cells in Tumor Angiogenesis
Roberto Tamma, Tiziana Annese, Doménico Ribatti
Biology of extracellular matrix (2022), pp. 375-397
Closed Access | Times Cited: 2
Radiotheranostics of neuroendocrine neoplasms: <i>quo vadis</i>
P. O. Rumyantsev
Almanac of Clinical Medicine (2021) Vol. 49, Iss. 4, pp. 297-303
Open Access | Times Cited: 1
Expression of FAP in Lung Cancer and Its Correlation With the Tumor Glucose Metabolism and the Histopathology
Xiaohong Chen, Xinran Liu, Lijuan Wang, et al.
Research Square (Research Square) (2022)
Open Access
Theranostic radiopharmacy for the nuclear medicine and molecular imaging
Meltem Ocak, Clemens Decristoforo
Elsevier eBooks (2022), pp. 235-242
Closed Access
The performance of [68Ga]Ga-FAPI-04 PET/CT in head and neck squamous cell carcinoma: a prospective comparison with [18F]FDG PET/CT
Yaqun Jiang, Bing Wen, Chongjiao Li, et al.
Research Square (Research Square) (2022)
Closed Access
Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung
Oliver Neels, Clemens Kratochwil, Marianne Patt
Der Nuklearmediziner (2021) Vol. 44, Iss. 02, pp. 135-151
Closed Access
Aktuelle radiopharmazeutische Entwicklungen für die theranostische Anwendung
Oliver Neels, Clemens Kratochwil, Marianne Patt
Radiopraxis (2021) Vol. 14, Iss. 04, pp. E83-E98
Closed Access
Previous Page - Page 2

Scroll to top